- The European Medicines Agency said doctors should be cautious about giving the drugs to patients who have risk factors for heart disease.
- US food and drug regulators will decide on Friday whether to recommend the sale of painkillers that have been linked to a high risk of heart attack and stroke.
- The FDA will create an independent body to oversee the safety of drugs already in the market place.
- Vioxx was withdrawn from shops last year but Merck said it would consider selling it if it gets FDA approval.
- The painkillers - called COX-2 inhibitors - are sold under brand names such as Celebrex and Vioxx.
- Approve showed that the risk of heart attack and stroke doubled in patients who had been taking the drug for at least 18 months.
